MLANA and vitiligo: It has been reported that vitiligo patients possess highfrequencies of circulating CD8+ T lymphocytes specific for Melan-A [52], andmelanoma patients who went through Melan-A specific CD8+ T cell infusionimmunotherapy demonstrated melanocyte loss in regions of normal skin [10].